SCHEMBL6503620

SCHEMBL6503620

N#Cc1cccc(-c2cccc(-n3cc(NC(N)=O)c(C(N)=O)n3)c2)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 2/20 0.44
ALDH1A1 P00352 1/20 0.44
TP53 P04637 1/20 0.44
TSHR P16473 1/20 0.44
HSD17B10 Q99714 1/20 0.44
ITK Q08881 1/20 0.43
SCN9A Q15858 1/20 0.42
GRM5 P41594 2/20 0.42
CSF1R P07333 1/20 0.40
PRKDC P78527 1/20 0.39
ATR Q13535 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
IKBKB O14920 1/20 0.39
CHUK O15111 1/20 0.39
IRAK4 Q9NWZ3 2/20 0.39
EGLN1 Q9GZT9 1/20 0.39
PARP1 P09874 1/20 0.39
LMNA P02545 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6498515 0.93 ITK (0.43) NPSR1ALDH1A1TP53TSHRHSD17B10
SCHEMBL6508710 0.84 IKBKB (0.47) ALDH1A1TP53HSD17B10ITKSCN9A
SCHEMBL6467349 0.84 ITK (0.46) ALDH1A1ITKSCN9ACSF1RATR
SCHEMBL6503522 0.84 ITK (0.48) ALDH1A1HSD17B10ITKSCN9AIKBKB
SCHEMBL6470279 0.83 SCN9A (0.42) ALDH1A1ITKSCN9AIRAK4PARP1
SCHEMBL6499548 0.83 ITK (0.45) ALDH1A1TP53HSD17B10ITKSCN9A
SCHEMBL6505904 0.83 ITK (0.48) ALDH1A1TP53ITKSCN9AGRM5
SCHEMBL6499924 0.83 IKBKB (0.48) ALDH1A1ITKSCN9AGRM5CA2
SCHEMBL6465740 0.83 IRAK4 (0.46) ALDH1A1TSHRHSD17B10ITKSCN9A
SCHEMBL6501255 0.83 ITK (0.45) ALDH1A1TP53HSD17B10ITKSCN9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050197338-A1 Substituted pyrazole urea compounds for the treatment of inflammation PHARMACIA AND UPJOHN COMPANY LLC 2005-09-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050197338-A1 Substituted pyrazole urea compounds for the treatment of inflammation IL4, ARG2, CASP4 NPSR1 1447/4885ALDH1A1 846/4885TP53 711/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.